Philip Stern

Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA.

Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada.

Revelstoke Capital Partners LLC (Revelstoke Capital Partners) is a private equity firm founded in 2013 by Simon A. Bachleda and Dale J. Meyer. The firm is headquartered in Denver, Colorado.

Franklin Advisers, Inc. is a mutual fund manager and registered investment advisor headquartered in San Mateo, California. The firm was founded in 1985 and is a subsidiary of Franklin Resources, Inc. (NYSE: BEN), a holding company that, together with its various subsidiaries is referred to as Franklin Templeton Investments. Franklin Advisers provides investment advisory and portfolio management services to US and non-US, registered open-end and closed-end funds and unregistered funds, as well as separate accounts.

Mercer Management Consulting, Inc. provides management consulting services. The company offers business design innovation, brand strategy, operational excellence, transformation, and portfolio strategy services. The firm was founded in 1990 and is located in New York, NY.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada

Quest Diagnostics Infectious Disease, Inc. provides diagnostic services. It offers anti infective surveillance and consultative services to the diagnosis, treatment, and management of infectious diseases. The company was founded in 1978 and is headquartered in Cypress, CA.

Founded in 1988, Beacon Securities Ltd. is an independent investment dealer located in Halifax, Nova Scotia. The firm specializes in research, underwriting, trading and sales. Their research focuses on companies with a connection to Atlantic Canada and with income trusts, both in Atlantic Canada and throughout Canada. Beacon's fixed-income team is involved in underwriting, origination, trading and sales. They have significant expertise in the Canadian fixed-income market with a focus on Eastern Canadian provincial, municipal and corporate debt.

Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.

Bloom Burton & Co. is an independent, Canadian broker/dealer headquartered in Toronto, Ontario. It was founded by Brian Bloom and Jolyon Burton in 2008. The firm offers bespoke execution services for healthcare institutional investors. They are active in all areas of the healthcare industry, including biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, life science tools, animal health, nutrition and wellness.

Cantor Fitzgerald Canada Corp. (CFCC) is a broker/dealer located in Toronto, Ontario. The firm is a subsidiary of Cantor Fitzgerald LP and their ultimate parent is CF Group Management, Inc. They offer clients an array of financial products and services in the equity and fixed-income capital markets. CFCC provides sales and trading, investment banking, asset management, market commentary and market data.

Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005.

ToHealth Ltd. provides health and wellbeing services. The private company is based in London, UK. The CEO of the British company is Robin Skinner.

Biofuse Medical Technologies, Inc. engages in the research and development of transformative tissue sealing and welding technology surgical devices. Its BioFuse technology can address a broad range of clinical applications. The company was founded on February 14, 2014 and is headquartered in Melbourne, FL.

Talon Pharmaceutical Services, Inc. provides Pharmaceutical services. The company was founded by Shawn Maddaford and David Vaughan and is headquartered in Mississauga, CA.

Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada.

Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes.

Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018.